Ocular Therapeutix Inc (OCUL)
8.52
-0.26
(-2.96%)
USD |
NASDAQ |
Nov 21, 16:00
8.89
+0.37
(+4.34%)
After-Hours: 20:00
Ocular Therapeutix Price to Book Value: 3.805 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.805 |
| November 20, 2024 | 3.921 |
| November 19, 2024 | 3.984 |
| November 18, 2024 | 3.881 |
| November 15, 2024 | 4.091 |
| November 14, 2024 | 4.430 |
| November 13, 2024 | 4.734 |
| November 12, 2024 | 4.734 |
| November 11, 2024 | 4.895 |
| November 08, 2024 | 4.940 |
| November 07, 2024 | 4.797 |
| November 06, 2024 | 4.868 |
| November 05, 2024 | 4.704 |
| November 04, 2024 | 4.570 |
| November 01, 2024 | 4.624 |
| October 31, 2024 | 4.686 |
| October 30, 2024 | 4.931 |
| October 29, 2024 | 5.029 |
| October 28, 2024 | 5.060 |
| October 25, 2024 | 4.958 |
| October 24, 2024 | 4.846 |
| October 23, 2024 | 4.833 |
| October 22, 2024 | 5.029 |
| October 21, 2024 | 5.060 |
| October 18, 2024 | 5.042 |
| Date | Value |
|---|---|
| October 17, 2024 | 4.935 |
| October 16, 2024 | 5.104 |
| October 15, 2024 | 4.552 |
| October 14, 2024 | 4.655 |
| October 11, 2024 | 4.352 |
| October 10, 2024 | 4.103 |
| October 09, 2024 | 4.139 |
| October 08, 2024 | 4.148 |
| October 07, 2024 | 4.219 |
| October 04, 2024 | 4.379 |
| October 03, 2024 | 4.108 |
| October 02, 2024 | 4.143 |
| October 01, 2024 | 4.032 |
| September 30, 2024 | 3.872 |
| September 27, 2024 | 3.583 |
| September 26, 2024 | 3.625 |
| September 25, 2024 | 3.649 |
| September 24, 2024 | 3.546 |
| September 23, 2024 | 3.492 |
| September 20, 2024 | 3.707 |
| September 19, 2024 | 3.732 |
| September 18, 2024 | 3.736 |
| September 17, 2024 | 3.616 |
| September 16, 2024 | 3.686 |
| September 13, 2024 | 3.715 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.593
Minimum
Apr 25 2024
132.44
Maximum
Jun 30 2023
23.10
Average
9.487
Median
Feb 20 2024
Price to Book Value Benchmarks
| 4D Molecular Therapeutics Inc | 0.668 |
| NovaBay Pharmaceuticals Inc | 3.299 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
| PS Ratio | 19.24 |
| PEG Ratio | -0.4088 |
| Price | 8.52 |
| Earnings Yield | -15.49% |
| Market Cap | 1.339B |
| PEGY Ratio | -0.4088 |